GB:HVO Stock Latest News
Company AnnouncementshVIVO appoints experienced healthcare executive Angela Hildreth as CFO to drive disciplined growth2w ago
Company AnnouncementsOpen Orphan Plc Bets on Order Book-Led Rebound1M ago
Company AnnouncementshVIVO reshapes board with new non-executive appointment1M ago
Company AnnouncementshVIVO Orderbook Surges as CRS Berlin Deal Positions Group for 2027 Growth1M ago
Company AnnouncementshVIVO Announces CFO Retirement and Interim Successor Amid Growth Push1M ago
Company AnnouncementshVIVO Sets Date for Interim Results and Schedules Analyst and Investor Events1M agoCompany AnnouncementshVIVO expands into dermatology and women’s health with acquisition of CRS Berlin2M ago
Company AnnouncementshVIVO Orderbook Doubles as Second-Half-Weighted Revenue Drives Growth Outlook3M ago
Company AnnouncementshVIVO appoints Grant Thornton as new auditor after tender3M ago
Company AnnouncementshVIVO wins Decoy Therapeutics consultancy mandate for next-generation respiratory antivirals5M ago
Company AnnouncementshVIVO grants performance-linked share options to senior leadership under 2024 LTIP5M ago
Company AnnouncementshVIVO Showcases Integrated Early-Stage Drug Development Platform at Capital Markets Day5M ago
Company AnnouncementshVIVO Shareholders Back All Resolutions at Annual General Meeting5M agoCompany AnnouncementshVIVO wins £6m influenza human challenge trial to test monoclonal antibody5M ago
- Company AnnouncementshVIVO Wins Landmark Phase III Human Challenge Contract for ILiAD’s Whooping Cough Vaccine6M ago
Company AnnouncementshVIVO Publishes 2025 Annual Report and Sets May AGM Date6M ago
Company AnnouncementsOpen Orphan Plc Earnings Call: Diversifying Amid Strain6M ago
Company AnnouncementshVIVO Reshapes Clinical Platform as 2025 Profits Slide on Sector Headwinds6M ago
Company AnnouncementshVIVO Rebrands as Unified End-to-End Clinical Development Partner6M agoCompany AnnouncementshVIVO seals Traws Pharma deal for Phase 2a influenza human challenge trial6M ago
